A Randomised, Double-Blind, Placebo-Controlled, Single-Centre Study to Determine the Effect of Intradermal AZD3161 on Quantitative Sensory Testing Variables in Normal and UVC Exposed Skin in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 11 Apr 2011
At a glance
- Drugs AZD 3161; Lidocaine
- Indications Pain
- Focus Therapeutic Use
- 11 Apr 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 11 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Feb 2011 Additional location [England] identified as reported by ClinicalTrials.gov.